跳转至内容
Merck

84050

Sigma-Aldrich

氯化钌 (III) 水合物

38.0-42.0% Ru basis

别名:

三氯化钌

登录查看公司和协议定价


About This Item

线性分子式:
RuCl3 · xH2O
CAS号:
分子量:
207.43 (anhydrous basis)
EC號碼:
MDL號碼:
分類程式碼代碼:
12352300
PubChem物質ID:

品質等級

形狀

powder

反應適用性

core: ruthenium
reagent type: catalyst

濃度

38.0-42.0% Ru

SMILES 字串

O.Cl[Ru](Cl)Cl

InChI

1S/3ClH.H2O.Ru/h3*1H;1H2;/q;;;;+3/p-3

InChI 密鑰

BIXNGBXQRRXPLM-UHFFFAOYSA-K

正在寻找类似产品? 访问 产品对比指南

應用

  • Photocatalytic disinfection: A study highlighted the synthesis of silver-ruthenium bimetallic zinc oxide nanocomposites using Callistemon viminalis leaf extract. These nanocomposites demonstrated effective photocatalytic disinfection properties against Escherichia coli, presenting a promising application in antimicrobial coatings (Jha et al., 2024).
  • Photoelectrocatalysis for hydrogen production: RuO(2)/TiO(2) heterostructures were investigated for their potential in photoelectrocatalytic hydrogen evolution, combining experimental and theoretical approaches to highlight the efficiency of ruthenium-based materials in renewable energy technologies (Kaikhosravi et al., 2023).
  • Electrochemical applications: The study explored the electrochemical properties of mixed RuOx/MnOx electrodes, prepared by thermal decomposition from different precursors, showing significant implications for their use in energy storage and conversion systems (Petrucci et al., 2022).
  • Catalysis and electrocatalysis: Unprotected and interconnected Ru(0) nano-chain networks were examined for their advantages in catalysis and electrocatalysis, illustrating the benefits of unprotected surfaces for improved reaction kinetics and efficiency (Anantharaj et al., 2016).

其他說明

与氧化剂发生氧化反应的催化剂;综述

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B

儲存類別代碼

8A - Combustible, corrosive hazardous materials

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

T. Hasegawa et al.
Chemistry Letters (Jpn), 1385-1385 (1985)
P.H.J. Carlsen et al
The Journal of Organic Chemistry, 46, 3936-3936 (1981)
E.S. Gore
Platinum Metals Rev., 27, 111-111 (1983)
Yao Zhang et al.
European journal of medicinal chemistry, 86, 449-455 (2014-09-10)
Ruthenium-based anticancer complexes have become increasingly popular for study over the last two decades. Although ruthenium complexes are currently being investigated in clinical trials, there are still some difficulties with their delivery and associated side effects. Human serum albumin (HSA)-based
Huaiyi Huang et al.
Dalton transactions (Cambridge, England : 2003), 44(35), 15602-15610 (2015-08-08)
Ruthenium complexes have been considered as promising substitutes for cisplatin in cancer chemotherapy. However, novel ruthenium-based therapies are faced with some limitations, such as unimpressive cytotoxicity toward solid tumors. Herein, we designed and synthesized phenyl-substituted terpyridyl ruthenium(ii) complexes ([Ru(tpy)(bpy)Cl](+) (Ru1)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门